Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Therapeutics

68.31
+0.20000.29%
Post-market: 68.510.2000+0.29%16:47 EDT
Volume:816.04K
Turnover:55.75M
Market Cap:5.43B
PE:8.85
High:69.28
Open:67.86
Low:67.57
Close:68.11
52wk High:69.88
52wk Low:35.95
Shares:79.44M
Float Shares:65.01M
Volume Ratio:1.14
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.72
EPS(LYR):-4.7276
ROE:-7740.12%
ROA:23.81%
PB:-26.27
PE(LYR):-14.45

Loading ...

PTC Therapeutics Inc expected to post a loss of $1.37 a share - Earnings Preview

Reuters
·
9 hours ago

PTC Therapeutics Director Emma Reeve Reports Disposal of Common Shares

Reuters
·
11 hours ago

How Investors May Respond To PTC Therapeutics (PTCT) Analysts' Optimism on Sephience Launch Momentum

Simply Wall St.
·
Yesterday

PTC Therapeutics Is Maintained at Buy by Jefferies

Dow Jones
·
Oct 29

U.S. RESEARCH ROUNDUP- BCB Bancorp, Cadence Design Systems, Intellia Therapeutics

Reuters
·
Oct 28

BRIEF-PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Oct 28

PTC Therapeutics Grants Stock Options and RSUs to New Employees

Reuters
·
Oct 28

PTC Therapeutics Inc. to Report Third Quarter 2025 Financial Results

Reuters
·
Oct 21

PTC Therapeutics price target raised to $87 from $76 at BofA

TIPRANKS
·
Oct 20

Pyxis Oncology appoints Alex Kane as Senior Vice President Investor Relations and Capital Markets

Reuters
·
Oct 09

PTC Therapeutics (PTCT) Receives a Buy from RBC Capital

TIPRANKS
·
Oct 09

RBC Raises Price Target on PTC Therapeutics to $70 From $63, Keeps Outperform Rating

MT Newswires Live
·
Oct 08

U.S. RESEARCH ROUNDUP- AGCO, Caterpillar, United Rentals

Reuters
·
Oct 08

PTC Therapeutics Director Emma Reeve Reports Disposal of Common Shares

Reuters
·
Oct 08

Neil Gregory Almstead, Chief Technical Ops Officer of PTC Therapeutics Inc., Reports Disposal of Common Shares

Reuters
·
Oct 08

PTC Therapeutics Exec. VP and CLO Mark Elliott Boulding Reports Disposal of Common Shares

Reuters
·
Oct 08

PTC Therapeutics Announces New Hire Compensation Plan with Stock Options and RSUs Under Nasdaq Inducement Grant

Reuters
·
Oct 02

Hold Rating on PTC Therapeutics Amid Competitive Gene Therapy Landscape and High-Risk Outlook

TIPRANKS
·
Sep 24

Mark Elliott Boulding, Exec. VP and CLO, Reports Disposal of PTC Therapeutics Inc. Common Shares

Reuters
·
Sep 16

Director David P. Southwell Reports Disposal of Common Shares in PTC Therapeutics Inc

Reuters
·
Sep 12